Dr. Bruce Liang continues to shape the future of Connecticut’s physician workforce and biomedical research as dean of the UConn School of Medicine, a role he has held since 2015.
Reappointed in July to a third five-year term, Liang has overseen significant changes at the state’s only public medical school.
Under his leadership, the school implemented the M Delta curriculum, shifting training toward team-based, active learning. The school also expanded its class size, exceeding targets set by Bioscience Connecticut, a state investment launched in 2011 to position Connecticut as a leader in biomedical research and innovation.
Liang has also helped drive record levels of research support: in recent years, the school surpassed $100 million annually in National Institutes of Health funding.
Liang’s influence extends beyond academics. He served more than two years as interim CEO of UConn Health, guiding the institution during a leadership transition.
A cardiovascular physician-scientist at the Pat and Jim Calhoun Cardiology Center, Liang is also the Ray Neag Distinguished Professor of Cardiovascular Biology and Medicine. Before joining UConn Health in 2002, he spent 13 years on the faculty of the University of Pennsylvania School of Medicine.